Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Non-adherence or non-persistence to intravitreal injection therapy for neovascular age-related macular degeneration: a mixed-methods systematic review
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Non-adherence or non-persistence to intravitreal injection therapy for neovascular age-related macular degeneration: a mixed-methods systematic review
Creator
Barratt, Jane
James, S
Eldem, Bora
Finger, Robert
Hirst, Ceri
Loewenstein, Anat
Mitchell, Paul
Okada, Mali
Paladini, Luciano
Wong, Tien
Barratt,
Talks, S
source
Elsevier; Medline; PMC
abstract
TOPIC: Systematic review of risk factors for non-adherence and non-persistence to intravitreal anti-vascular endothelial growth factor (anti-VEGF) injection therapy for neovascular age-related macular degeneration (nAMD). CLINICAL RELEVANCE: Lack of adherence (non-adherence) or under-treatment (non-persistence) with respect to evidence from clinical trials remains a significant barrier to optimizing real-world outcomes for patients with nAMD. Contributing factors and strategies to address this are poorly understood. METHODS: Studies that reported factors for non-adherence and/or non-persistence to anti-VEGF therapy as well as studies examining strategies to improve this were included. Trial eligibility and data extraction were conducted according to Cochrane review methods. Risk of bias was assessed using the Mixed Method Assessment Tool and certainty of evidence evaluated according to the GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative Research) tool. Data were collated descriptively. RESULTS: Of the 1284 abstract results screened, 124 articles were assessed in full and 37 studies met the inclusion criteria. Definitions of non-adherence and non-persistence varied or were not reported. Non-persistence occurred early with up to 50% of patients stopping treatment by 24 months. High rates of non-adherence were similarly reported, occurring in 32 – 95% of patients. Certainty of this finding was downgraded to moderate level due to heterogeneity in definitions used across studies. Multiple factors determine non-adherence and non-persistence, including at condition, therapy, patient, social/economic and health systems/health-care team level. Moderate quality evidence points to lower baseline vision and poorer response to treatment as condition-related variables. The effects of other factors were of lower certainty, predominantly due to small numbers and potential biases in retrospective assessment. Although many factors are non-modifiable (e.g., patient co-morbidity), other factors are potentially correctable (e.g., lack of transport or mismatched patient expectations). Evidence on strategies to improve adherence and persistence is limited, but where available, these have proven effective. CONCLUSIONS: Awareness of factors related to poor patient adherence and persistence in nAMD could help identify at-risk populations and improve real world outcomes. Further work is required to develop uniform definitions as well as establishing high quality evidence on interventions that can be easily implemented.
has issue date
2020-08-05
(
xsd:dateTime
)
bibo:doi
10.1016/j.ophtha.2020.07.060
bibo:pmid
32763265
has license
no-cc
sha1sum (hex)
a7441cdb4ff5ec32b6498c32c6fa7bf3069e4479
schema:url
https://doi.org/10.1016/j.ophtha.2020.07.060
resource representing a document's title
Non-adherence or non-persistence to intravitreal injection therapy for neovascular age-related macular degeneration: a mixed-methods systematic review
has PubMed Central identifier
PMC7403101
has PubMed identifier
32763265
schema:publication
Ophthalmology
resource representing a document's body
covid:a7441cdb4ff5ec32b6498c32c6fa7bf3069e4479#body_text
is
schema:about
of
named entity 'systematic review'
named entity 'MIXED'
named entity 'FINGER'
named entity 'Barometer'
named entity 'age-related macular degeneration'
named entity 'intravitreal injection'
named entity 'mixed-methods'
named entity 'https'
named entity 'mixed-methods'
named entity 'doi'
named entity 'Non-adherence'
named entity 'Non-adherence'
named entity 'systematic review'
named entity 'Non-adherence'
named entity 'WONG'
named entity '3 4'
named entity 'PROOF'
named entity 'NEOVASCULAR AGE-RELATED MACULAR DEGENERATION'
named entity 'Ophthalmology'
named entity 'AMD'
named entity 'intravitreal injection'
named entity 'neovascular age-related macular degeneration'
named entity 'doi'
named entity 'IS A'
named entity 'INITIATIVE'
named entity 'CITE'
named entity 'neovascular age-related macular degeneration'
named entity 'INTRAVITREAL INJECTION'
named entity 'VISION'
named entity 'PERSISTENCE'
named entity 'TALKS'
named entity 'NON-'
named entity 'METHODS'
named entity 'PERSISTENCE'
named entity 'PRE'
named entity 'joint initiative'
named entity 'systematic review'
named entity 'JOINT'
named entity 'WORK'
named entity 'ACKNOWLEDGEMENTS'
named entity 'ADHERENCE'
named entity 'intravitreal injection'
named entity 'systematic review'
named entity 'article'
named entity 'Please'
named entity 'Okada'
named entity 'systematic review'
named entity 'doi'
named entity 'Hirst'
named entity 'therapy'
named entity 'DOI'
named entity 'METHODS'
named entity 'AMD'
named entity 'INJECTION THERAPY'
named entity 'age-related macular degeneration'
named entity 'cite'
named entity 'therapy'
named entity 'injection'
named entity 'Finger'
named entity 'Vision'
named entity 'joint'
named entity 'Ophthalmology'
named entity 'Journal'
named entity 'systematic review'
named entity 'intravitreal'
named entity 'SYSTEMATIC REVIEW'
named entity 'NON-'
named entity 'INJECTION THERAPY'
named entity 'JOURNAL '
named entity 'This'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 2
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software